Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

RGCRGC

Showing 1 of 7 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in REGENCELL BIOSCIENCE HLDGS L

No. Qube Research & Technologies exited its RGC (Regencell Bioscience) position in Q3 2024. Its Q2 2024 13F listed 13 shares worth $44. Qube Research & Technologies first reported RGC in Q1 2022 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$0.15
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used